Your browser doesn't support javascript.
loading
Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy.
Klein, Oliver; Kee, Damien; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie; Power, Daniel; Cebon, Jonathan; Behren, Andreas.
Afiliación
  • Klein O; Olivia Newton-John Cancer Research Institute, Melbourne, Australia; Department of Medical Oncology, Austin Health, Melbourne, Australia. Electronic address: oliver.klein@onjcri.org.au.
  • Kee D; Department of Medical Oncology, Austin Health, Melbourne, Australia; Department of Medical Oncology, Peter McCallum Cancer Centre, Melbourne, Australia.
  • Markman B; Department of Medical Oncology, Alfred Health, Melbourne, Australia; Monash University, Melbourne, Australia.
  • Carlino MS; Blacktown Hospital and the University of Sydney, Sydney, Australia.
  • Underhill C; Albury-Wodonga Regional Cancer Centre, Albury-Wodonga, Australia.
  • Palmer J; Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Australia.
  • Power D; ThermoFisher Scientific Ltd.
  • Cebon J; Olivia Newton-John Cancer Research Institute, Melbourne, Australia; Department of Medical Oncology, Austin Health, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Australia.
  • Behren A; Olivia Newton-John Cancer Research Institute, Melbourne, Australia; School of Cancer Medicine, La Trobe University, Australia.
Cancer Cell ; 39(5): 592-593, 2021 05 10.
Article en En | MEDLINE | ID: mdl-33930312

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno CTLA-4 / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antígeno CTLA-4 / Inmunoterapia / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
...